FDA Approved and Recalled drugs from Jan 2012 to May 2012

FDA-Approved Drugs in 2012

Dermatology/Plastic Surgery

Sklice (ivermectin) lotion; Sanofi Pasteur; For the treatment of head lice, Approved February 2012

Endocrinology

Korlym (mifepristone); Corcept Therapeutics; For the control of hyperglycemia in adults with endogenous Cushing’s syndrome, Approved February 2012

Hematology

Elelyso (taliglucerasealfa); Pfizer Inc; For the treatment of Gaucher disease, Approved May 2012

Omontys (peginesatide); Affymax; For the treatment of anemia due to chronic kidney disease, Approved March 2012

Musculoskeletal

Stendra (avanafil); Vivus; For the treatment of erectile dysfunction, Approved April 2012

Oncology

Afinitor (everolimus); Novartis Pharmaceuticals Corporation; For the treatment of renal angiomyolipoma associated with tuberous sclerosis complex, Approved April 2012

Erivedge (vismodegib); Genentech; For the treatment of basal cell carcinoma, Approved January 2012

Inlyta (axitinib); Pfizer; For the treatment of advanced renal cell carcinoma, Approved January 2012

 

click here for more

Add Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.